![](/images/graphics-bg.png)
Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PETCT Imaging in Prostate Cancer Patients
المؤلفون المشاركون
Partanen, Kaarina
Joensuu, Timo
Rasulova, Nigora
Kairemo, Kalevi
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-06-02
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Background.
In this retrospective analysis we assessed the role of [18F]-FACBC-PET/CT in the prostatic cancer staging.
Procedure.
30 first [18F]-FACBC-PET/CT images of 26 patients (68.1 ± 5.8 years) were analyzed.
PET/CT findings were compared with PSA concentrations, with PSA doubling times (PDT), and with correlative imaging.
Results.
On 16 [18F]-FACBC (53.3%) scans, 58 metabolically active lesions were found.
12 (20.7%) lesions corresponding to the local relapse were found in prostate/prostate bed and seminal vesicles, 9 (15.5%) lesions were located in regional lymph nodes, 10 (17.2%) were located in distal lymph nodes, and 26 (44.8%) metabolically active lesions were found in the skeleton.
In one case, focal uptake was found in the brain, confirmed further on MRI as meningioma.
The mean S-PSA level in patients with positive [18F]-FACBC findings was 9.5 ± 16.9 μg/L (0.54–69 μg/L) and in patients with negative [18F]-FACBC findings was 1.96 ± 1.87 μg/L (0.11–5.9 μg/L), but the difference was not statistically significant.
However, the PSA doubling time (PDT) in patients with positive findings was significantly shorter than PDT in patients with negative findings: 3.25 ± 2.09 months (0.3–6 months) versus 31.2 ± 22.02 months (8–84 months), P<0.0001.
There was a strong positive correlation between PSA value and number of metabolically active lesions (R=0.74) and a negative correlation between PDT and number of metabolically active lesions (R=-0.56).
There was a weak negative correlation between PDT and SUVmax (R=-0.30).
Conclusion.
According to our preliminary clinical experience, [18F]-FACBC-PET may play a role in in vivo restaging of an active prostate cancer, especially in patients with a short S-PSA doubling time.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Kairemo, Kalevi& Rasulova, Nigora& Partanen, Kaarina& Joensuu, Timo. 2014. Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PETCT Imaging in Prostate Cancer Patients. BioMed Research International،Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-461927
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Kairemo, Kalevi…[et al.]. Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PETCT Imaging in Prostate Cancer Patients. BioMed Research International No. 2014 (2014), pp.1-7.
https://search.emarefa.net/detail/BIM-461927
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Kairemo, Kalevi& Rasulova, Nigora& Partanen, Kaarina& Joensuu, Timo. Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PETCT Imaging in Prostate Cancer Patients. BioMed Research International. 2014. Vol. 2014, no. 2014, pp.1-7.
https://search.emarefa.net/detail/BIM-461927
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-461927
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)